LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

UNH

396.24

+3.1%↑

AZN

184.48

+1.46%↑

Home・Elenco Azioni・Pfizer

Pfizer

Chiusa

SettoreSettore sanitario

25.88 0.35

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

25.73

Massimo

26.08

Metriche Chiave
By Trading Economics
Entrata	4.3B 2.7B
Vendite	-3.1B 14B
P/E Media del settore	19.702 49.8
EPS	0.75
Rendimento da dividendi	6.7
Margine di Profitto	18.656
Dipendenti	75,000
EBITDA	4.5B 5.2B

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+13.72% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	6.70% 2.25%
Utili prossimi	4 ago 2026
Prossima data del Dividendo	12 giu 2026
Prossima data del' Ex Dividendo	24 lug 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-2.5B 147B
Apertura precedente	25.53
Chiusura precedente	25.88

Notizie sul Sentiment di mercato

By Acuity

43%

57%

116 / 346 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

22.855 / 23.85 Supporto e resistenza

Pfizer Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 mag 2026, 11:31 UTC

Utili

Pfizer 1Q Revenue Rises But Profit Falls Amid Boosted R&D Spending

5 mag 2026, 18:12 UTC

Utili

BioNTech to Slash 22% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mag 2026, 13:54 UTC

Utili

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

5 mag 2026, 12:35 UTC

Utili

Pfizer Posts Better-Than-Expected Revenue, Profit -- WSJ

5 mag 2026, 11:06 UTC

Utili

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates -- Barrons.com

5 mag 2026, 10:47 UTC

Utili

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

5 mag 2026, 10:47 UTC

Utili

Pfizer Still Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

5 mag 2026, 10:46 UTC

Utili

Pfizer 1Q Revenue of Launched, Acquired Products Rose 22% Operationally >PFE

5 mag 2026, 10:46 UTC

Utili

Pfizer 1Q Revenue Rose 7% Operationally Excluding Contributions From Comirnaty, Paxlovid >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer Reaffirms 2026 Guidance >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer 1Q Rev $14.5B >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer 1Q EPS 47c >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer 1Q Net $2.69B >PFE

5 mag 2026, 10:45 UTC

Utili

Pfizer 1Q Adj EPS 75c >PFE

5 mag 2026, 10:36 UTC

Azioni calde

Stocks to Watch: Palantir, HSBC, Intel, AMD -- WSJ

23 apr 2026, 21:48 UTC

Acquisizioni, Fusioni, Takeovers

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 apr 2026, 20:07 UTC

Acquisizioni, Fusioni, Takeovers

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mar 2026, 11:02 UTC

Discorsi di Mercato

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mar 2026, 12:50 UTC

Utili

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mar 2026, 11:18 UTC

Utili

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mar 2026, 09:43 UTC

Azioni calde

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 feb 2026, 21:51 UTC

Utili

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:17 UTC

Utili

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 feb 2026, 21:36 UTC

Utili

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 19:56 UTC

Utili

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 19:46 UTC

Utili

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 17:35 UTC

Utili

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 17:30 UTC

Utili

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

Confronto tra pari

Modifica del prezzo

Pfizer Previsione

Obiettivo di Prezzo

By TipRanks

13.72% in crescita

Previsioni per 12 mesi

Media 29.35 USD 13.72%

Alto 36 USD

Basso 25 USD

Basato su 21 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pfizer - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

21 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 21 che hanno fornito valutazioni azionarie a Pfizer - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

22.855 / 23.85Supporto e resistenza

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

116 / 346 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.